ScholarIQanswers from OpenAlex & ORCID
Nita Patel
ResearcherPublications, citations & collaboration network
Nita Patel is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Nita Patel have?
ScholarIQindexed works
Nita Patel has 105 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Nita Patel have?
ScholarIQcitation count
Nita Patel has 8,051 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Nita Patel?
ScholarIQh-index
Nita Patel has an h-index of 34 in OpenAlex.
What is the i10-index of Nita Patel?
ScholarIQi10-index
Nita Patel has an i10-index of 65 in OpenAlex.
What is the ORCID of Nita Patel?
ScholarIQorcid
The ORCID for Nita Patel is on the source record.
What is the OpenAlex record for Nita Patel?
ScholarIQopenalex
The OpenAlex for Nita Patel is on the source record.
What are the most-cited papers on Nita Patel?
ScholarIQmost cited works
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech, Gary Albert, Iksung Cho, Andreana Robertson, Patricia Reed, Susan Neal, Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark, Haixia Zhou, Gale Smith, Nita Patel, Matthew B. Frieman, Robert Haupt, James Logue, Marisa E. McGrath, Stuart Weston, Pedro A. Piedra, Chinar Desai, Kathleen Callahan, Maggie Lewis, Patricia Price-Abbott, Neil Formica, Vivek Shinde, Louis Fries, Jason D. Lickliter, Paul Griffin, Bethanie Wilkinson, Gregory M. Glenn
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
Bryce D. Smith, Rebecca L. Morgan, Geoff A. Beckett, Yngve Falck–Ytter, Deborah Holtzman, Chong‐Gee Teo, Amy Jewett, Brittney Baack, David B. Rein, Nita Patel, Miriam J. Alter, Anthony Yartel, John W. Ward
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Jing-Hui Tian, Nita Patel, Robert Haupt, Haixia Zhou, Stuart Weston, Holly Hammond, James Logue, Alyse D. Portnoff, James A. Norton, Mimi Guebre‐Xabier, Bin Zhou, Kelsey Jacobson, Sonia Maciejewski, Rafia Khatoon, Malgorzata Wisniewska, Will Moffitt, Stefanie Kluepfel-Stahl, Betty Ekechukwu, James F. Papin, Sarathi Boddapati, C. Jason Wong, Pedro A. Piedra, Matthew B. Frieman, Michael J. Massare, Louis Fries, Karin Lövgren Bengtsson, Linda Stertman, Larry Ellingsworth, Gregory M. Glenn, Gale Smith
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
Sandhya Bangaru, Gabriel Ozorowski, Hannah L. Turner, Aleksandar Antanasijevic, Deli Huang, Xiaoning Wang, Jonathan L. Torres, Jolene K. Diedrich, Jing-Hui Tian, Alyse D. Portnoff, Nita Patel, Michael J. Massare, John R. Yates, David Nemazee, James C. Paulson, Greg Glenn, Gale Smith, Andrew B. Ward
Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract
Herren Wu, David S. Pfarr, Syd Johnson, Yambasu A. Brewah, Robert M. Woods, Nita Patel, Wendy I. White, James F. Young, Peter A. Kiener